Výsledky vyhledávání - "RAMS Co-Investigators"

Akademický článek

Prediction of primary non-response to methotrexate therapy using demographic, clinical and psychosocial variables: results from the UK Rheumatoid Arthritis Medication Study (RAMS)

Autor: Jamie C. Sergeant, Kimme L. Hyrich, James Anderson, Kamilla Kopec-Harding, Holly F. Hope, Deborah P. M. Symmons, RAMS Co-Investigators, Anne Barton, Suzanne M. M. Verstappen

Publikováno v: Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-11 (2018)

Abstract Background Methotrexate (MTX) remains the disease-modifying anti-rheumatic drug of first choice in rheumatoid arthritis (RA) but response varies. Predicting non-response to MTX could enable earlier access to alternative or additional medicat

Externí odkaz: https://doaj.org/article/b9365c14a0254f469ffa9ea986a090ac

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Do people with rheumatoid arthritis maintain their physical activity level at treatment onset over the first year of methotrexate therapy?

Autor: Mark Lunt, James M. Gwinnutt, Husain Alsafar, Kimme L. Hyrich, Suzanne M M Verstappen, Rams co-investigators, Anne Barton

Publikováno v: Rheumatology (Oxford, England)

Objectives To describe how many people with RA reduce their baseline physical activity level over the first year of MTX treatment, and which factors predict this. Methods Data came from the Rheumatoid Arthritis Medication Study (RAMS), a prospective

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::821db593749499177a215a65fc2e71f0
https://doi.org/10.1093/rheumatology/keab060

Zobrazit plný text záznamu

Changes in the illness perceptions of patients with rheumatoid arthritis over the first year of methotrexate therapy

Autor: Sam Norton, James M. Gwinnutt, Mark Lunt, Suzanne M M Verstappen, Anne Barton, Lis Cordingley, Rams co-investigators, Kimme L. Hyrich

Publikováno v: University of Manchester-PURE
Rheumatology (Oxford, England)

Objectives To describe the illness perceptions of patients with RA over the first year of MTX treatment, and the association between illness perceptions and outcomes. Methods Data came from the Rheumatoid Arthritis Medication Study (RAMS), a UK multi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28959896fd5910bf0a7ea07bb5dd6110
https://doi.org/10.1093/rheumatology/keaa615

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Is the relationship between deprivation and outcomes in rheumatoid arthritis mediated by body mass index? A longitudinal cohort study.

Autor: Witkam R; Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester, UK., Gwinnutt JM; Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester, UK., Humphreys J; Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester, UK.; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Verstappen SMM; Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester, UK.; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2023 Jul 05; Vol. 62 (7), pp. 2394-2401.

Zobrazit plný text záznamu

O06 Baseline predictors of methotrexate-related adverse events in methotrexate-naïve patients with RA

Autor: Rams co-investigators, Kimme L. Hyrich, Ahmad A Sherbini, James M. Gwinnutt, Suzanne M M Verstappen

Publikováno v: Rheumatology. 60

Background/Aims Methotrexate (MTX) is the most common treatment for rheumatoid arthritis (RA). The prevalence of adverse events (AEs) associated with MTX treatment for RA have been studied extensively, but there are limited data on the predictors of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::789614407eb683f49298869269c00a1d
https://doi.org/10.1093/rheumatology/keab246.005

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The predictors of and reasons for non-adherence in an observational cohort of patients with rheumatoid arthritis commencing methotrexate

Autor: James Bluett, Suzanne M M Verstappen, Anne Barton, Rams co-investigators, Kimme L. Hyrich, Lis Cordingley, Holly Hope, Jamie C. Sergeant, J. Anderson

Publikováno v: Hope, H, Hyrich, K, Anderson, J, Bluett, J, Sergeant, J, Barton, A, Cordingley, L, Verstappen, S & RAMS Co-Investigators 2019, ' THE PREDICTORS OF AND REASONS FOR NON-ADHERENCE IN AN OBSERVATIONAL COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS COMMENCING METHOTREXATE ', Rheumatology (Oxford), vol. 59, no. 1, pp. 213-223 . https://doi.org/10.1093/rheumatology/kez274

Objective In order to develop interventions to optimize MTX use for the treatment of RA we evaluated the rate of, reasons for and predictors of MTX non-adherence during the first 6 months of therapy. Methods The Rheumatoid Arthritis Medication Study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e842df7555ab2fb1efdc919fc92551ee
https://doi.org/10.1093/rheumatology/kez274

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání